Locations:
SearchAdvertisement
Reassurance from the lipid outcomes trial with the highest percentage female enrollment to date
Additional analyses of the two trials presented at 2023 ESC Congress
Robust reductions in cardiac events seen in high-risk patients without prior events
Findings bolster the oral drug as an option for primary and secondary prevention
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Updated guidance on identification and strategies for management
Intermittent statin dosing & bempedoic acid refresh the mix of options
Reduces muscle pain caused by cholesterol-lowering drugs
Advertisement
Advertisement